tailieunhanh - Hypofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: Study protocol of the phase I HYDRA trial

Radiotherapy (RT) is the standard of care for most advanced head and neck squamous cell carcinoma (HNSCC) and results in an unfavorable 5-year overall survival of 40%. Despite strong biological rationale, combining RT with immune checkpoint inhibitors does not result in a survival benefit. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN